InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 15.64
-0.19 (-1.20%)
Apr 17, 2026, 1:25 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 32.23 billion as of April 16, 2026. Its market cap has increased by 92.83% in one year.
Market Cap
32.23B
Enterprise Value
26.18B
Revenue
2.64B
Ranking
n/a
PE Ratio
37.43
Stock Price
15.64
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 32.23B, an increase of 162.52%. That is a compound annual growth rate of 17.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 32.23B | 36.08% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 48.24B |
| Shanghai Junshi Biosciences | 45.46B |
| Shanghai Henlius Biotech | 44.92B |
| Shanghai Bao Pharmaceuticals | 29.34B |
| Genscript Biotech | 29.12B |
| Duality Biotherapeutics | 28.65B |
| TransThera Sciences (Nanjing) | 28.05B |
| Keymed Biosciences | 23.36B |